[[{“value”:”
Compass Pathways is laying off employees and delaying its Phase 3 trials, signaling growing economic pressures and a changing public perception of psychedelic medicine. […]
The post The First Major For-Profit Psychedelic Company Is Experiencing Major Setbacks appeared first on DoubleBlind Mag.
“}]] DoubleBlind Mag Read More
